Business Wire

Ant Group Achieves 2022 Carbon Neutrality Across Its Operations for the Second Consecutive Year

21.4.2023 15:33:00 EEST | Business Wire | Press release

Share

According to figures certified by the China Environmental United Certification Center (“CEC”), Ant Group has once again achieved operational carbon neutrality (Scope 1 & 2) for the second consecutive year, following the company’s initial achievement in 2021. This marks another concrete step for Ant Group towards fulfilling its pledge made in March 2021 to achieve net zero carbon emissions across Scope 1, 2 & 3 by 2030.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230420006073/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Through a combination of reduction, substitution and offset measures, Ant Group achieved carbon neutrality in Scope 1 & 2 in 2022. (Graphic: Business Wire)

The Greenhouse Gas Protocol (“Protocol”) classifies a company's Greenhouse Gas Emissions (“GHG”) into Scope 1, 2 and 3. Based on the Protocol, Ant Group, in its Carbon Neutrality Road Map, released in April 2021 , defined its GHG emissions scopes as follows:

  • Scope 1: direct & fugitive emissions from the combustion of fossil fuel by the company’s owned or controlled sources.
  • Scope 2: indirect emissions from the consumption of purchased energy, such as heating or cooling networks.
  • Scope 3: indirect emissions which occur in the company's value chain, such as emissions from the use of leased data centers, employees’ business travel and their daily commute.

According to CEC certified figures, in 2022, after reductions and substitutions, Ant Group's greenhouse gas (GHG) emissions for Scope 1 & 2 totaled 21,087.93 tonnes of CO2e, which were fully offset by the company’s purchase of carbon credits from a Verified Carbon Standard (VCS) Project, namely the CECIC Gansu Yumen Changma No.3 Wind Farm Project (VCS Project No.728).

CEC certified figures indicate that Ant Group reduced a total of 68,665.35 tonnes of CO2e across Scope 1, 2 & 3 in 2022, up 81% from 37,909.87 tonnes in 2021. This is equivalent to taking more than 28,000 cars off the road each year, assuming each car is driven 12,000 kilometers per year at 0.203 kilogram of CO2e per kilometer. The CEC was an official service provider to the 2022 Winter Olympics, helping the Olympic Committee measure the effectiveness of its carbon reduction efforts.

This reduction was mainly due to the implementation of green computing technologies. These technologies reduced about 62,000 tonnes of CO2e, which accounted for more than 99% of all carbon emissions reduced in Scope 3 during 2022. This was a 110% improvement over the 30,000 tonnes of CO2e that green computing technologies reduced in 2021.

“At Ant Group, we believe a company’s commercial value creation should go hand in hand with social value creation,“ said Yijie Peng, Chief Sustainability Officer of Ant Group. “Technological innovations has always been an important pathway for us to achieve this goal. We are committed to reaching net zero carbon emissions by 2030 and will continue to explore innovative ways to help reduce our carbon footprint and that of the industry.”

Ant Group has been developing and adopting green computing technologies since 2019. These technologies include Green AI, a series of technologies such as elastic management, GPU memory pooling and virtualization, which make large-scale model training more efficient.

For example, ATorch, Ant Group's PyTorch extension library, can double the utilization rate of AI computing power in large GPU cluster configurations compared to Megatron-DeepSpeed, an opensource deep learning optimization software suite. The use of ATorch has led to energy efficiency gains and carbon emission reductions for AI model training operations, which the company uses to iterate its AI-based products and services for better customer experience.

Ant Group also uses other green computing technologies, such as online-offline hybrid deployment, cloud-native time-shared scheduling, AI-based auto scaling, and OceanBase enterprise-level distributed relational database to help improve energy efficiency of data centers.

In 2022, Ant Group joined the Low Carbon Patent Pledge and granted free patent access to its green computing technologies.

The CEC’s carbon neutrality certificate for Ant Group for the year 2022 is publicly available on the Information Platform for Carbon Neutrality, which is affiliated with the Environmental Development Center of China’s Ministry of Ecology and Environment.

About Ant Group

Ant Group aims to create the infrastructure and platform to support the digital transformation of the service industry. It strives to enable all consumers and small and micro businesses to have equal access to financial and other services that are inclusive, green and sustainable.

For more information, please visit our website at www.antgroup.com or follow us on Twitter @AntGroup.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Enquiries
Zhumei WANG
zhumei.wzm@antgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OPEX® Corporation Introduces the Velo™ Series of Premium Desktop and High Production Document Scanners10.2.2026 11:00:00 EET | Press release

OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, has announced the launch of its Velo™ Series powered by InoTec, a new class of premium desktop and free standing high production scanners. The OPEX Velo scanners are engineered to deliver exceptional performance, reliability and image quality and offer industry-standard TWAIN/ISIS connectivity to help simplify deployment into existing capture environments. These state-of-the-art scanners are ideal for service bureaus, government agencies, healthcare providers and enterprise capture operations. “The Velo Series powered by InoTec introduces an entirely new class of scanners to the OPEX portfolio, expanding the options available to both our current customers and organizations considering OPEX for the first time,” said Dann Worrell, President, Document and Mail Automation, OPEX. “By broadening our offerings, we can better align the right solution with

New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval10.2.2026 11:00:00 EET | Press release

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations. Equipped with ZOLL’s innovative Real BVM Help® and exclusive Real CPR Help® technology, Zenix gives healthcare pro

IEO and Laife Reply Join Forces to Digitalise the Biobank Through Artificial Intelligence10.2.2026 11:00:00 EET | Press release

The Pathology Division of the European Institute of Oncology (IEO) and Laife Reply, the Reply Group company specialised in AI and Big Data solutions for the healthcare sector, have entered into a collaboration to develop Bianca, the first project in Italy aimed at creating an AI-based digital biobank designed as an integral part of clinical diagnostic practice. The initiative is part of a broader technological innovation journey that structurally integrates research and development into routine diagnostic processes in pathology, transforming the traditional histopathological sample workflow into an end-to-end digital ecosystem. The complete digitalisation of histopathological and molecular diagnostic workflows aims to make analysis more efficient, scalable and reproducible, laying the foundations for the evolution of AI-supported oncological diagnostics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210610418/en/ On this

Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution10.2.2026 11:00:00 EET | Press release

Expereo is redefining what’s possible for global enterprises at CiscoLive Amsterdam with the launch of its enhanced Digital Case Management (DCM) capability in expereoOne. As the world-leading managed Network as a Service (NaaS) provider, Expereo is putting customers firmly in control - slashing resolution times, cutting through operational noise and ensuring everyone is aligned every step of the way. With DCM, service issues are no longer bottlenecks: instead, enterprises experience swift, transparent outcomes, with every stakeholder empowered through a single, real-time view of progress. DCM is designed around a simple objective: enable enterprises to resolve issues faster, with greater clarity and full control, through a fully digital, software-first workflow inside expereoOne. Customers can create, manage and track cases end-to-end within a single platform, ensuring predictable, consistent and aligned service experiences across their global network footprint. Unified, digital-first

U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 10:15:00 EET | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living with NT1. NT1 is a chronic, rare neurological disease caused by a loss of orexin and characterized by excessive daytime sleepiness and cataplexy (sudden loss of muscle tone). This results in a spectrum of physical, cognitive and psychosocial effects that can have a debilitating impact on many aspects of a person’s life, including work, education and social interactio

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye